Researchers engineered EpCAM-targeted CAR-NK cells, which exhibited specific cytotoxicity against EpCAM-positive human colorectal cancer cell lines, namely, HCT-8 and HCT-116. This evidence concerns the gene EPCAM and colorectal cancer.